Comparative Evaluation of Two Different Marketed Brands of Enalapril maleate
Abstract
Efficacy of pharmaceuticals dosage form generally depends on their formulation properties and manufacturing methods, hence it is likely that the quality of dosage form may vary. Renin acts on angiotensinogen to form angiotensin I, which is converted to angiotensin II by angiotensin-converting enzyme (ACE). Angiotensin II, a potent vasoconstrictor increases blood pressure by increasing vasopressin production and aldosterone secretion. Enalaprilat, the active metabolite of enalapril, inhibits ACE, hence decreases levels of angiotensin II resulting in less vasoconstriction and decreased blood pressure. The study was exclusively experimental that used IP and other standard books to check in vitro quality of enalapril maleate tablet using different analytical techniques and procedure. Test for weight variation, hardness, friability, disintegration time, and dissolution were conducted. The dissolution test was performed at pH 6.8 for both the brands of the tablet. Further all the tablets passed weight variation, hardness, friability and disintegration test as per the pharmacopoeial standard. Hence we can conclude that both the brands of tablets are equal and both the brands contain equal quantity of active pharmaceutical ingredient (API). Both the brands having higher and lower costs exert similar action.
Keywords: Enalapril maleate, In Vitro, Dissolution test, Enalapril
DOI
https://doi.org/10.22270/jddt.v8i6-s.2127References
Alderborn G. Tablet and compaction. In: the science of dosage design. Aulton ME (eds), 3rd edition, Churchill Livingstone Elsevier, 2007.p.7.
Rudnic EM and Schwartz JB. In: Remington, The science and practice of pharmacy, 21st edition, Lippincott Williams & Wilkins, 2005.p.889.
Halbert GW. Pharmaceutical Development. In: Griffin JP, Grady JO and Wells FO editors. The Text Book of Pharmaceutical Medicine. Greystone Books Ltd., Caulside Drive, Antrim, N. Ireland, 1993.pp.39-40.
Martino PD, Joiris E and Martelli S. Particle interaction of lubricated or unlubricated binary mixtures according to their particle size and densification mechanism II. Farmaco. 2004; 59(9):747-758.
British Pharmaceutical Codex (1994). Principles and practice of Pharmaceutics, 12th ed., The Pharmaceutical Press, London; 1994 pp. 9-11.
Gohel MC. A review of Co-processed Directly compressible excipients. J. Pharm. Sci., 2005; 8(1):76-93.
Jivraj M, Martini LG and Thomson CM. An overview of different excipients useful for the direct compression of tablets. Pharm. Sci. Technol., 2002; 3(2):58-63.
Oates JA and Brown NJ (2008). In: Joel G. Hardman and LEE E. Limbird. Goodman Gilman’s. The Pharmacological Basis of Therapeutics. Joel G. Hardman and Lee E. Limbird (eds), 12th edition, McGraw hill; 2008 pp.893-894.
United States Pharmacopoeia 31. Roukville: The United States Pharmacopeial Convention, 2008; pp.2056-2058.
Bandameedi R, Pandiyan S, Formulation and Evaluation of Floating Tablets. J App Pharm 2016; 8:209.
British Pharmacopoeia. The Stationary Office, London, 2004; p.2499, A358.
Block LH and Yu ABC (2001). In: Shargel L, Mutnick AH, Souney PF and Swanson LN (editors). Comprehensive Pharmacy Review, 4th ed. Lippincott.
Kumari PK, Sankar G, Sowjanya P, Madhubabu S, Stability indicating RP-HPLC metod development and validation. J Pharma Care health sys. 2014; 1:4.
Rani et al: Comparative in vitro evaluation of different commercially available brands of pantoprazole tablets, IJPSR; 2012; 1108-1111.
Chapter 711: Dissolution. In: United States Pharmacopoeia 31 (USP 31): National Formulary 26 (NF 26); 2008: P. 267-274.
Published
Abstract Display: 846 
PDF Downloads: 887 How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.